JTOPYRT

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
JTOPYRT
Generic name
SALICYLIC ACID PAD
Manufacturer
Guangzhou Yixiang Trading Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
3dfb8f94-f734-de7d-e063-6394a90abed8
SPL ID
4de48753-dca1-524e-e063-6294a90a5b2d
Version
2
Effective date
2026-03-25
Source export date
2026-09-28
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:39:20
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product Avoid contact with eyes. If contact occurs, rinse thoroughly with water. Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid unnecessary sun exposure and use a sunscreen during the day. Stop use and ask a doctor if You experience any discomfort, abnormal skin reactions, or if skin irritation becomes severe or worsens. Pregnancy or breast feeding section If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children In case of accidental ingestion, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.